Share
Glaucoma Australia is thrilled to announce that applications for the annual Glaucoma Australia ‘Quinlivan’ Research Grants are now open. The successful recipient(s) will be unveiled on World Sight Day, October 10th, 2024.
Expressing gratitude to the late benefactor Mr. Marcus Quinlivan and his family, Glaucoma Australia CEO, Mr. Adam Check, remarked, “We are very grateful to our late benefactor Mr. Marcus Quinlivan and his family for their generosity and dedication to glaucoma research. The Glaucoma Australia ‘Quinlivan’ Research Grants have made significant contributions to Australian medical and social research into glaucoma. We are now very proud to announce applications are open for the 2024 round of our ‘Quinlivan’ Research Grants which will continue to fund research that supports our mission.”
Chair of Glaucoma Australia Research Committee, Professor Bang Bui, emphasised the organisation’s commitment to fostering high-quality glaucoma research in Australia. “Glaucoma Australia is committed to funding and supporting high quality glaucoma research in Australia. The broad aims of research we support are to improve the lives of people with glaucoma through better glaucoma detection and treatment. We are excited to facilitate the innovative research of academics who drive progress in glaucoma management,” said Professor Bui.
Established in 2006 by the late Mr. Marcus Quinlivan in honour of his father, the William A Quinlivan Research Fund has been instrumental in advancing glaucoma research in Australia. To date, Glaucoma Australia has allocated over $1.7 million towards glaucoma research aimed at enhancing the quality of life for individuals diagnosed with glaucoma through improved detection, treatment, and monitoring.
In the current funding round, Glaucoma Australia pledges to invest up to $200,000, anticipating between 1 and 4 grants to be awarded. All projects are expected to be completed within 3 years of grant allocation, and seed fund grants can be utilised to apply for further funding with NHMRC or other agencies.
Glaucoma Australia is dedicated to supporting research focused on four key domains:
- Increasing the rate and reliability of early detection of glaucoma
- Developing new treatments or improving the treatment experience
- Improving the quality and experience of monitoring the condition progression and maintaining better population wide statistics
- Providing prevention or management tools to improve the quality of life for people with glaucoma.
Applications will be accepted from May 1st, 2024, until 5 pm (AEST) on Friday, June 14, 2024. Interested applicants can apply by visiting Glaucoma Australia's website.
Funding research to enhance glaucoma detection, treatment, and the lives of individuals with glaucoma is fundamental to Glaucoma Australia's mission to prevent glaucoma blindness. Contributions to this research can be made through tax-deductible donations online or by texting SIGHT to 0400 662 662.
Research suggests a large language model (LLM) artificial intelligence (AI) system can match, or sometimes do better than, human eye doctors in diagnosing and treating patients with glaucoma and retina disease.
Glaucoma Australia is thrilled to welcome Senior Orthoptist Patient Educator Val Tosswill to provide comprehensive support to patients enrolled in its SiGHTWiSE Patient Support Program.
This World Glaucoma Week (10–16 March 2024), Glaucoma Australia is urging all Australians to have their eyes checked, as well as reminding those with a glaucoma diagnosis to adhere to their treatment to slow its progression and save precious sight.